HYPREVENTION
28.9.2020 14:57:11 CEST | Business Wire | Press release
Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will be used to execute the commercialization plans for the US spinal fracture market. The V-STRUT© Vertebral Implant is indicated for use in the treatment of vertebral fractures. In May 2019, a US patent was granted for V-STRUT© and in March 2020, the device received FDA-510(k) clearance.
“We are delighted that our existing investors have shown confidence in our product development efforts and commercialization plans for the US market by increasing their investment in the company,” says Cecile Vienney, CEO.
The Hyprevention team has entered into a commercial relationship with DAWA Medical and has received several orders for the product from enthusiastic customers. DAWA Medical, a regional distributor of medical products, will promote sales in Florida, Illinois, Texas and Oklahoma. In addition to DAWA the company is in discussion with other commercial partners to bring the innovative V-STRUT© product to the US spinal injury market.
About V-STRUT©
V-STRUT© Vertebral Implant is an implantable medical device made of INVIBIO PEEK Optima® polymer indicated for use in the treatment of vertebral fractures in the thoracic and lumbar spine. It is intended to be used in combination with Teknimed F20® bone cement. V-STRUT© is patented and cleared in the USA. The device was developed with the support of Key Opinion Leaders in the spine surgery. A deep literature review allowed to identify unmet clinical needs such as subsequent and adjacent fractures after treatment in osteoporotic and cancer patients. The device was developed to address this clinical need thanks to its soft material, close to normal bone, and an unique pedicle anchorage.
About Hyprevention
Hyprevention was founded in 2010 in France by 3 orthopedic and spine surgeons and an experimented Executive Team. The company aims to develop innovative products addressing bone fragility as the consequence of osteoporosis and bone metastasis, thanks to the unique technique STRUTPLASTY® intended to reinforce the bone with polymer implant combined with bone cement.
About DAWA Medical
DAWA Medical is a master distributor for the USA and Canada. DAWA acts as US Agent, Initial Importer, warehousing and shipping. The company has a large network of distributors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200928005423/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026 Esri User Conference to Focus on Creating a More Intelligent World with GIS25.6.2026 14:00:00 CEST | Press release
More Than 18,000 Attendees Expected for World's Largest GIS Conference in San Diego The 2026 Esri User Conference will be held from July 13 to 17 in San Diego, California. This year's theme is "GIS—Creating a more intelligent world." Jack Dangermond, president and founder of Esri, and Kristine Tompkins, president and cofounder of Tompkins Conservation, will be the keynote speakers in the Plenary Session. Esri, the global leader in geographic information system (GIS) technology, today announced speakers and the conference theme for the 2026 Esri User Conference. The conference will be held from July 13 to 17 at the San Diego Convention Center in San Diego, California. This year's theme of "GIS—Creating a more intelligent world" will emphasize how GIS turns the science of "where" into shared understanding and coordinated action—at the scale of communities, enterprises, and the planet. Kristine Tompkins, president and cofounder of Tompkins Conservation, will join Esri president Jack Dange
Copeland Releases FY2025 Global Impact Report Highlighting Energy Efficiency, Safety and Innovation Progress25.6.2026 14:00:00 CEST | Press release
Scope 1 and Scope 2 greenhouse gas emissions declined nearly 20%1Near-term reduction targets validated by the Science Based Targets InitiativeGlobal Total Recordable Incident Rate improved to 0.21, outperforming the industry average by over 90% Copeland, a global leader in compression technologies and controls solutions, has released its second annual Global Impact Report. The report highlights the company’s Fiscal Year 2025 (FY25) progress across environmental sustainability, workplace safety and community impact, guided by its Purpose, Performance and People pillars. Copeland has advanced its sustainability commitments through three strategic areas of focus: Performance-Driven Decarbonization: Copeland reduced Scope 1 and Scope 2 greenhouse gas emissions by 20% year-over-year, advancing toward its Science Based Targets initiative (SBTi)-validated goal of a 55% absolute reduction by FY33, using FY23 as a baseline.2 Renewable energy procurement and onsite solar generation accounted for
ExaGrid Wins 4 Industry Awards at the Storage Awards25.6.2026 14:00:00 CEST | Press release
ExaGrid has won 11 awards for its Tiered Backup Storage so far in 2026 ExaGrid®, the world’s largest independent backup storage vendor providing Tiered Backup Storage with the most Comprehensive Security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that the company was honored with four industry awards during the 23rd annual Storage Awards ceremony, “The Storries,” held in London on June 18, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625584191/en/ The ExaGrid team headed to the stage four times throughout the Storage Awards ceremony in London to accept awards for ExaGrid Tiered Backup Storage. Photo courtesy of Storage Awards. ExaGrid was named Data Protection Company of the Year, Immutable Storage Company of the Year, Storage Company of the Year, andjointly received the Storage Solution of the Year - Corporate award with key channel partner Convergent Technology. ExaGrid continues
SUTEL Deploys Tecnotree Platform to Modernize Mobile Prepaid Registration and Strengthen Digital Security and Trust in Costa Rica25.6.2026 13:26:00 CEST | Press release
New Tecnotree platform will provide a faster, safer, and more accessible registration process for prepaid mobile users The Superintendence of Telecommunications (SUTEL) is advancing the modernization of Costa Rica’s Mobile Prepaid Registration System through the implementation of a new technological platform provided by Tecnotree designed to strengthen user identification processes, enhance regulatory compliance, and improve the overall customer experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625307287/en/ This initiative is part of SUTEL’s ongoing efforts to promote digital transformation within the telecommunications sector while reinforcing security, transparency, and trust in digital communications across the country. The new Tecnotree platform incorporates advanced identity verification mechanisms, biometric authentication capabilities, and fraud prevention tools that will enable a more efficient and secur
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b25.6.2026 13:00:00 CEST | Press release
The appointments position MRM Health for its next key clinical, partnering and financing milestones MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors as the Company enters a pivotal phase of growth. With its lead program, MH002, in Phase 2b clinical development, recent FDA Fast Track designation and a €55 million Series B financing, MRM Health is strengthening its Board to support the Company through its next clinical, strategic and financing milestones. Michel Detheux, PhD, has been appointed Chairman of the Board of Directors, taking over from Werner Cautreels. Prof. Dr. med. Hans-Jürgen Wörle joins the Board as an Independent Director. “MRM Health is entering a pivotal phase, with MH002 advancing into Phase 2b clinical development and significant momentum across the business. The appointments of Michel and Hans-Jürgen significantly stre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom